Nature:检测黑素细胞基因组,有望预测黑色素瘤风险

2020-10-22 张佳兴 生物探索

皮肤黑色素瘤是由黑色素细胞(皮肤中产生色素的细胞)引起的皮肤癌,光照是形成黑色素瘤的主要诱变因素。对黑色素瘤肿瘤组织的测序发现,体细胞突变与之密切相关,因此早期诊断意义重大。

皮肤黑色素瘤是由黑色素细胞(皮肤中产生色素的细胞)引起的皮肤癌,光照是形成黑色素瘤的主要诱变因素。对黑色素瘤肿瘤组织的测序发现,体细胞突变与之密切相关,因此早期诊断意义重大。但目前尚不清楚这些突变是否发生在肿瘤形成过程中,以及在肿瘤转化过程中其积累速度是否加快。

由于黑色素细胞在皮肤中稀疏分布,整体细胞测序并不适用于检测黑色素细胞突变。单个细胞的基因分型的研究也较少见,而且目前还没有关于黑色素细胞分型的研究。

2020年10月7日,美国加州大学旧金山分校海伦·狄勒家庭综合癌症中心的A. Hunter Shain课题组研究人员在《Nature》在线发表题为“The genomic landscapes ofindividual melanocytes from human skin”的研究论文,阐明了人类单个黑色素细胞的基因组特征,为黑色素瘤的发病提供了新的理论依据。

研究人员从6例健康人的19个部位采集了正常的皮肤样本。皮肤活检取自无皮肤癌病史的逝者或皮肤癌供者的瘤周组织。随后,研究人员将表皮细胞组织培养约两周,并进行单细胞分类和克隆。经过一系列的实验和生物信息学方案,研究人员克服了黑色素细胞基因分型相关的障碍,最终获得133个黑色素细胞。

皮肤细胞基因型分析工作流程

与预期一致,研究结果表明阳光下暴晒的黑色素细胞有更多的突变。通常情况下,背部和四肢的皮肤只是间歇性地暴露在阳光下,累积的阳光照射量比面部、颈部和头皮的皮肤要低,但是然而与面部的黑色素细胞相比,背部和四肢的细胞有更多的突变。

人类皮肤中黑素细胞的基因组

随后,研究人员在24个不同的细胞中检测到29个致病性突变。其中,有许多能激活丝裂原活化蛋白激酶(MAPK)通路的突变。包括MAPK通路负调节因子如NF1,CBL和RASA2功能缺失的突变,同时也有BRAF,NRAS和MAP2K1功能增强或改变的突变。但是,BRAFV600E突变作为黑色素瘤最常见的突变,未在该研究中检测到。

黑色素瘤不同的演化过程

总的来说,该研究克服了黑色素细胞基因分型相关的障碍,通过研究人类单个黑色素细胞的基因组,揭示了黑色素瘤的起源,有望通过检测黑色素细胞突变的数量和类型来预测或衡量紫外线损伤和黑色素瘤风险。

原始出处:

Jessica Tang, Eleanor Fewings, Darwin Chang, et al.The genomic landscapes of individual melanocytes from human skin.Nature. 2020 Oct 7. doi: 10.1038/s41586-020-2785-8.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1884743, encodeId=98261884e4336, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sun Apr 11 21:32:43 CST 2021, time=2021-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1680697, encodeId=f09e168069e23, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Sat Oct 31 15:32:43 CST 2020, time=2020-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895158, encodeId=0b81895158ea, content=对黑色素瘤,有了全新的认识, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/AFEE88F419F5C2EE00A4D2529684DE09/100, createdBy=94611950576, createdName=ms5233340938792882, createdTime=Wed Oct 28 20:09:48 CST 2020, time=2020-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1559031, encodeId=93ab1559031da, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Sat Oct 24 03:32:43 CST 2020, time=2020-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1565040, encodeId=4f9b1565040ea, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Sat Oct 24 03:32:43 CST 2020, time=2020-10-24, status=1, ipAttribution=)]
    2021-04-11 liye789132251
  2. [GetPortalCommentsPageByObjectIdResponse(id=1884743, encodeId=98261884e4336, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sun Apr 11 21:32:43 CST 2021, time=2021-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1680697, encodeId=f09e168069e23, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Sat Oct 31 15:32:43 CST 2020, time=2020-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895158, encodeId=0b81895158ea, content=对黑色素瘤,有了全新的认识, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/AFEE88F419F5C2EE00A4D2529684DE09/100, createdBy=94611950576, createdName=ms5233340938792882, createdTime=Wed Oct 28 20:09:48 CST 2020, time=2020-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1559031, encodeId=93ab1559031da, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Sat Oct 24 03:32:43 CST 2020, time=2020-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1565040, encodeId=4f9b1565040ea, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Sat Oct 24 03:32:43 CST 2020, time=2020-10-24, status=1, ipAttribution=)]
    2020-10-31 sunylz
  3. [GetPortalCommentsPageByObjectIdResponse(id=1884743, encodeId=98261884e4336, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sun Apr 11 21:32:43 CST 2021, time=2021-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1680697, encodeId=f09e168069e23, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Sat Oct 31 15:32:43 CST 2020, time=2020-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895158, encodeId=0b81895158ea, content=对黑色素瘤,有了全新的认识, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/AFEE88F419F5C2EE00A4D2529684DE09/100, createdBy=94611950576, createdName=ms5233340938792882, createdTime=Wed Oct 28 20:09:48 CST 2020, time=2020-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1559031, encodeId=93ab1559031da, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Sat Oct 24 03:32:43 CST 2020, time=2020-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1565040, encodeId=4f9b1565040ea, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Sat Oct 24 03:32:43 CST 2020, time=2020-10-24, status=1, ipAttribution=)]
    2020-10-28 ms5233340938792882

    对黑色素瘤,有了全新的认识

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1884743, encodeId=98261884e4336, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sun Apr 11 21:32:43 CST 2021, time=2021-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1680697, encodeId=f09e168069e23, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Sat Oct 31 15:32:43 CST 2020, time=2020-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895158, encodeId=0b81895158ea, content=对黑色素瘤,有了全新的认识, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/AFEE88F419F5C2EE00A4D2529684DE09/100, createdBy=94611950576, createdName=ms5233340938792882, createdTime=Wed Oct 28 20:09:48 CST 2020, time=2020-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1559031, encodeId=93ab1559031da, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Sat Oct 24 03:32:43 CST 2020, time=2020-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1565040, encodeId=4f9b1565040ea, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Sat Oct 24 03:32:43 CST 2020, time=2020-10-24, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1884743, encodeId=98261884e4336, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sun Apr 11 21:32:43 CST 2021, time=2021-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1680697, encodeId=f09e168069e23, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Sat Oct 31 15:32:43 CST 2020, time=2020-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895158, encodeId=0b81895158ea, content=对黑色素瘤,有了全新的认识, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/AFEE88F419F5C2EE00A4D2529684DE09/100, createdBy=94611950576, createdName=ms5233340938792882, createdTime=Wed Oct 28 20:09:48 CST 2020, time=2020-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1559031, encodeId=93ab1559031da, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Sat Oct 24 03:32:43 CST 2020, time=2020-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1565040, encodeId=4f9b1565040ea, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Sat Oct 24 03:32:43 CST 2020, time=2020-10-24, status=1, ipAttribution=)]

相关资讯

PD1+溶瘤病毒,奥源和力公布OrienX010一项黑色素瘤Ib期研究结果

9月19日,来自北京肿瘤医院郭军团队的斯璐教授在CSCO2020大会上报告了重组人GM-CSF单纯疱疹病毒注射液(OrienX010)联合特瑞普利单抗(PD-1单抗)治疗在可完全切除的 III期及IV

JCO:CheckMate 066试验| 纳武单抗治疗晚期黑色素瘤的5年随访结果

CheckMate 066试验研究了纳武单抗单药疗法作为既往未治疗过的BRAF野生型晚期黑色素瘤的一线疗法的疗效和安全性。现对该试验随访5年的结果进行汇报。

人各有“痣”:痣出现这些变化,有恶变的可能!黑色素瘤不能小看

黑痣在每个人身上都会出现,如果有细心观察的话就会发现,很多人的脖子后面都长了一颗黑痣。部分人是出生之后就有,而有的人是后期长起来的。人脖子有黑痣,是好是坏?脖子后面有黑痣其实是个很正常的现象,不必太过

Lancet oncol:纳武单抗维持高危黑色素瘤术后辅助治疗的长期疗效明显优于伊匹单抗

经过4年随访,证实了在切除的IIIB-C或IV期黑色素瘤患者中,与伊匹单抗相比,纳武单抗具有持续的无复发存活获益,提示纳武单抗具有长期治疗益处。

“模拟病毒的药物”可帮助免疫系统靶向狡猾的癌细胞

加州大学洛杉矶分校(UCLA)的研究人员发现,一种像病毒一样激活人体自然防御能力的药物可能使某些隐形的黑色素瘤细胞对免疫系统可见,从而可以通过免疫疗法更好地攻击这些癌细胞。

免疫联合疗法O药+Y药:黑色素瘤辅助治疗的III期临床失败

百时美施贵宝的免疫联合疗法(PD-1单抗Opdivo联合CTLA-4单抗Yervoy):在已完成手术切除的高危黑色素瘤患者中未达到实验终点。